Reining in big business has its pitfalls
President Biden last month signed an executive order intended to limit the clout of big business and enhance competitive prospects for small and mid-sized companies. The sweeping document — which includes 72 specific elements, among them provisions instructing the Food and Drug Administration to clear the way for prescription drug imports from Canada (a very